Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
24,551,816
-
Share change
-
-4,037,808
-
Total reported value
-
$40,388,162
-
Put/Call ratio
-
134%
-
Price per share
-
$1.64
-
Number of holders
-
87
-
Value change
-
-$6,876,383
-
Number of buys
-
43
-
Number of sells
-
60
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q2 2025
As of 30 Jun 2025 Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) had 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,551,816 shares of stock of the company.
Largest 10 holders included CAS Investment Partners, LLC, VANGUARD GROUP INC, 683 Capital Management, LLC, KPS Global Asset Management UK Ltd, WORLDLY PARTNERS MANAGEMENT, LLC, MIRABELLA FINANCIAL SERVICES LLP, BlackRock, Inc., LPL Financial LLC, RBF Capital, LLC, and Lane Generational LLC.
This table shows 87 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.